Diagnostics
-
Courtesy of Labcorp
Labcorp acquires MLM Medical Labs in global expansion
Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa.
By Nick Paul Taylor • Sept. 9, 2026 -
Retrieved from Elucid on September 08, 2026
Elucid raises $55M to commercialize cardiovascular imaging platform
Elucid, which gained a large medtech company as an investor, plans to grow industry partnerships as it looks to expand its AI-powered imaging platform.
By Nick Paul Taylor • Sept. 8, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Permission granted by GE HealthCare
GE HealthCare secures CE mark for photon-counting CT device
GE HealthCare is challenging Siemens Healthineers in the market for a technology that is designed to provide clearer images than traditional CT systems.
By Nick Paul Taylor • Sept. 1, 2026 -
Permission granted by Cleveland Diagnostics
Cleveland Diagnostics hires new CFO
Valerie Dixon arrives at Cleveland Diagnostics as the company works to commercialize its prostate cancer test in the U.S.
By Nick Paul Taylor • Aug. 27, 2026 -
Getty Images
Guardant Health ordered to pay $245M in patent dispute
A U.S. court ruled Guardant willfully infringed two core patents for DNA sequencing methods in a case brought by TwinStrand Biosciences and the University of Washington.
By Susan Kelly • Aug. 26, 2026 -
Courtesy of Qiagen
Qiagen names new CEO
Jonathan Pratt will take over the role on Sept. 1. The announcement ends Qiagen’s nearly 10-month search for a new chief executive.
By Nick Paul Taylor • Aug. 25, 2026 -
National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.
By Susan Kelly • Aug. 25, 2026 -
Permission granted by Guardant Health
Q&AHow Guardant aims to expand cancer screening with a blood test
Sam Asgarian, Guardant Health’s vice president of clinical development, discusses the progress and challenges of blood-based testing in colorectal and multicancer screening.
By Susan Kelly • Aug. 18, 2026 -
Getty Images
Baylor Genetics discloses patient information exposed in cyberattack
A third party may have accessed test results and Social Security numbers held by the genetic testing company.
By Nick Paul Taylor • Aug. 18, 2026 -
Permission granted by Johnson & Johnson
J&J’s Monarch robot wins FDA nod for AI features
The lung bronchoscopy robot adds improvements that include new tools for pre-procedure planning and updated navigation and visual guidance during the procedure.
By Susan Kelly • Aug. 17, 2026 -
Getty Images
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm
European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.
By Susan Kelly • Aug. 13, 2026 -
Courtesy of Grail
FDA sets advisory panel for Galleri multicancer screening test
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.
By Susan Kelly • Aug. 7, 2026 -
Permission granted by Danaher
Danaher promotes Julie Sawyer Montgomery to CEO
The executive has led Danaher’s diagnostics business, where she helped triple operating profit during her tenure and oversaw the recent acquisition of Masimo.
By Susan Kelly • Aug. 4, 2026 -
Courtesy of Siemens Healthineers
Siemens Healthineers names new head of the Americas
The company disclosed the appointment of João Seabra the day before cutting its full-year sales outlook in response to continued challenges at its diagnostics division.
By Nick Paul Taylor • Aug. 3, 2026 -
Courtesy of Siemens Healthineers
Siemens Healthineers, Cleveland Clinic form 10-year alliance
The deal to provide a range of imaging and therapeutic technologies to Cleveland Clinic extends the partners’ longtime relationship and follows a recent 10-year pact between Siemens Healthineers and Mayo Clinic.
By Nick Paul Taylor • July 31, 2026 -
Permission granted by Freenome
Freenome secures FDA nod for blood-based colorectal cancer test
Abbott will market Freenome’s SimpleScreen CRC test in the U.S., alongside its Cologuard stool test. SimpleScreen will compete with Guardant Health’s Shield blood test for colorectal cancer screening.
By Susan Kelly • July 27, 2026 -
Stringer via Getty Images
GE HealthCare inks 10-year, $500M alliance with Catholic Health
The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and UC San Diego.
By Nick Paul Taylor • July 21, 2026 -
Getty Images
Tempus to buy cancer test maker Personalis for $1.5B
Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.
By Elise Reuter • July 20, 2026 -
Courtesy of Exact Sciences/Business Wire
Abbott reports diagnostics growth since $21B Exact Sciences buy
The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.
By Elise Reuter • July 16, 2026 -
Alamy
Q&AAbbott’s cancer diagnostics vision: ‘There’s always a hunger to make these tests better’
Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, discusses the future of the field.
By Susan Kelly • July 15, 2026 -
Getty Images
Freenome colorectal cancer test data improve on earlier results
The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.
By Susan Kelly • July 13, 2026 -
Courtesy of Boston Scientific
Top 10 medtech deals in the first half of 2026
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
By Nick Paul Taylor • July 6, 2026 -
Courtesy of Business Wire
Guardant’s Shield colon cancer blood test snags UnitedHealth coverage
One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category of blood-based cancer testing.
By Susan Kelly • July 2, 2026 -
Permission granted by Agilent
Agilent finalizes Biocare Medical takeover
The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.
By Nick Paul Taylor • June 26, 2026 -
Justin Sullivan via Getty Images
Labcorp rolls out colorectal cancer screening test nationwide
The Geneoscopy test competes with Exact Sciences’ Cologuard for the U.S. colorectal cancer screening market.
By Nick Paul Taylor • June 25, 2026
